Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis

Abstract Iodine-125 (I-125) radioactive seed implantation is used for the local treatment of hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer effects remain incompletely understood. In this study, we report that hsa_circ_0000647 (circSEC11A) is highly expressed...

Full description

Bibliographic Details
Main Authors: Dong Li, Wujie Wang, Bin Liu, Die Jin, Yang Wang, Guanghui He, Lei Guo, Wen Liu, Yuliang Li
Format: Article
Language:English
Published: Nature Publishing Group 2023-08-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-023-01593-w
_version_ 1797453911075848192
author Dong Li
Wujie Wang
Bin Liu
Die Jin
Yang Wang
Guanghui He
Lei Guo
Wen Liu
Yuliang Li
author_facet Dong Li
Wujie Wang
Bin Liu
Die Jin
Yang Wang
Guanghui He
Lei Guo
Wen Liu
Yuliang Li
author_sort Dong Li
collection DOAJ
description Abstract Iodine-125 (I-125) radioactive seed implantation is used for the local treatment of hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer effects remain incompletely understood. In this study, we report that hsa_circ_0000647 (circSEC11A) is highly expressed after I-125 treatment in HCC cell lines and tissues and is a key regulator of I-125-induced anticancer effects. CircSEC11A acts as a competing endogenous RNA (ceRNA) to sponge miR-3529-3p, promoting the expression of zinc fingers and homeoboxes 2 (ZHX2) and enhancing I-125-induced anticancer effects. Dual-luciferase reporter assay, RNA pull-down, RNA immunoprecipitation, and fluorescence in situ hybridization were thereafter performed to verify the interaction among the molecules. Anticancer effects were detected using CCK-8, flow cytometry, TUNEL, EdU, transwell, and wound healing assays. Furthermore, ZHX2 transcriptionally inhibits GADD34, a negative regulator of endoplasmic reticulum stress (ERS), to enhance I-125- induced anticancer effects in vivo and in vitro. In conclusion, we characterized circSEC11A as a novel regulator of I-125-induced anticancer effects in HCC via miR-3529-3p/ZHX2/GADD34 axis-mediated ERS. Thus, circSEC11A may act as a potential therapeutic target for I-125 implantation in the clinic.
first_indexed 2024-03-09T15:29:41Z
format Article
id doaj.art-dcb34ff126604f538c8389c90c0ed29a
institution Directory Open Access Journal
issn 2058-7716
language English
last_indexed 2024-03-09T15:29:41Z
publishDate 2023-08-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj.art-dcb34ff126604f538c8389c90c0ed29a2023-11-26T12:21:33ZengNature Publishing GroupCell Death Discovery2058-77162023-08-019111610.1038/s41420-023-01593-wCharacterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axisDong Li0Wujie Wang1Bin Liu2Die Jin3Yang Wang4Guanghui He5Lei Guo6Wen Liu7Yuliang Li8Department of Interventional Medicine, The Second Hospital of Shandong UniversityDepartment of Interventional Medicine, The Second Hospital of Shandong UniversityDepartment of Interventional Medicine, The Second Hospital of Shandong UniversityDepartment of Interventional Medicine, The Second Hospital of Shandong UniversityDepartment of Interventional Medicine, The Second Hospital of Shandong UniversityDepartment of Interventional Medicine, Weifang Second People’s HospitalDepartment of Vascular Anomalies and Interventional Radiology, Children’s Hospital Affiliated to Shandong UniversityDepartment of Interventional Medicine, The Second Hospital of Shandong UniversityDepartment of Interventional Medicine, The Second Hospital of Shandong UniversityAbstract Iodine-125 (I-125) radioactive seed implantation is used for the local treatment of hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer effects remain incompletely understood. In this study, we report that hsa_circ_0000647 (circSEC11A) is highly expressed after I-125 treatment in HCC cell lines and tissues and is a key regulator of I-125-induced anticancer effects. CircSEC11A acts as a competing endogenous RNA (ceRNA) to sponge miR-3529-3p, promoting the expression of zinc fingers and homeoboxes 2 (ZHX2) and enhancing I-125-induced anticancer effects. Dual-luciferase reporter assay, RNA pull-down, RNA immunoprecipitation, and fluorescence in situ hybridization were thereafter performed to verify the interaction among the molecules. Anticancer effects were detected using CCK-8, flow cytometry, TUNEL, EdU, transwell, and wound healing assays. Furthermore, ZHX2 transcriptionally inhibits GADD34, a negative regulator of endoplasmic reticulum stress (ERS), to enhance I-125- induced anticancer effects in vivo and in vitro. In conclusion, we characterized circSEC11A as a novel regulator of I-125-induced anticancer effects in HCC via miR-3529-3p/ZHX2/GADD34 axis-mediated ERS. Thus, circSEC11A may act as a potential therapeutic target for I-125 implantation in the clinic.https://doi.org/10.1038/s41420-023-01593-w
spellingShingle Dong Li
Wujie Wang
Bin Liu
Die Jin
Yang Wang
Guanghui He
Lei Guo
Wen Liu
Yuliang Li
Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis
Cell Death Discovery
title Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis
title_full Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis
title_fullStr Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis
title_full_unstemmed Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis
title_short Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis
title_sort characterization of circsec11a as a novel regulator of iodine 125 radioactive seed induced anticancer effects in hepatocellular carcinoma via targeting zhx2 gadd34 axis
url https://doi.org/10.1038/s41420-023-01593-w
work_keys_str_mv AT dongli characterizationofcircsec11aasanovelregulatorofiodine125radioactiveseedinducedanticancereffectsinhepatocellularcarcinomaviatargetingzhx2gadd34axis
AT wujiewang characterizationofcircsec11aasanovelregulatorofiodine125radioactiveseedinducedanticancereffectsinhepatocellularcarcinomaviatargetingzhx2gadd34axis
AT binliu characterizationofcircsec11aasanovelregulatorofiodine125radioactiveseedinducedanticancereffectsinhepatocellularcarcinomaviatargetingzhx2gadd34axis
AT diejin characterizationofcircsec11aasanovelregulatorofiodine125radioactiveseedinducedanticancereffectsinhepatocellularcarcinomaviatargetingzhx2gadd34axis
AT yangwang characterizationofcircsec11aasanovelregulatorofiodine125radioactiveseedinducedanticancereffectsinhepatocellularcarcinomaviatargetingzhx2gadd34axis
AT guanghuihe characterizationofcircsec11aasanovelregulatorofiodine125radioactiveseedinducedanticancereffectsinhepatocellularcarcinomaviatargetingzhx2gadd34axis
AT leiguo characterizationofcircsec11aasanovelregulatorofiodine125radioactiveseedinducedanticancereffectsinhepatocellularcarcinomaviatargetingzhx2gadd34axis
AT wenliu characterizationofcircsec11aasanovelregulatorofiodine125radioactiveseedinducedanticancereffectsinhepatocellularcarcinomaviatargetingzhx2gadd34axis
AT yuliangli characterizationofcircsec11aasanovelregulatorofiodine125radioactiveseedinducedanticancereffectsinhepatocellularcarcinomaviatargetingzhx2gadd34axis